A randomized, double-blind, placebo-controlled trial of quetiapine in patients with bipolar disorder, mixed or depressed phase, and alcohol dependence

Alcoholism: Clinical and Experimental Research

Volumn 38, Issue 7, 2014, Pages 2113-2118

  Sherwood Brown, E ^a   Davila, Domingo ^a   Nakamura, Alyson ^a   Carmody, Thomas J ^a   John Rush, A ^b   Lo, Alexander ^a   Holmes, Traci ^a   Adinoff, Bryon ^a   Caetano, Raul ^a   Swann, Alan C ^c   Sunderajan, Prabha ^a   Bret, Mary E ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Alcohol dependence; Bipolar disorder; Depression; Mania; Quetiapine

Indexed keywords

DELAYED RELEASE FORMULATION; DIBENZOTHIAZEPINE DERIVATIVE; NEUROLEPTIC AGENT; QUETIAPINE;

ADULT; ALCOHOLISM; BIPOLAR DISORDER; COMPLICATION; CONTROLLED STUDY; DELAYED RELEASE FORMULATION; DOUBLE BLIND PROCEDURE; DRINKING BEHAVIOR; DRUG EFFECTS; FEMALE; HUMAN; MALE; PSYCHIATRIC DIAGNOSIS; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL; THERAPEUTIC USE; TREATMENT OUTCOME; WITHDRAWAL SYNDROME; YOUNG ADULT;

ADULT; ALCOHOL DRINKING; ALCOHOLISM; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; CRAVING; DELAYED-ACTION PREPARATIONS; DIAGNOSIS, DUAL (PSYCHIATRY); DIBENZOTHIAZEPINES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; PSYCHIATRIC STATUS RATING SCALES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84904387351     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1111/acer.12445     Document Type: Article

References (33)

1. Aagaard J, Vestergaard P (1990) Predictors of outcome in prophylactic lithium treatment: a 2-year prospective study. J Affect Disord 18:259-266.
2. Barnes TR (1989) A rating scale for drug-induced akathisia. Br J Psychiatry 154:672-676.
3. Bauer MS, Williford WO, Dawson EE, Akiskal HS, Altshuler L, Fye C, Gelenberg A, Glick H, Kinosian B, Sajatovic M (2001) Principles of effectiveness trials and their implementation in VA Cooperative Study #430: 'reducing the efficacy-effectiveness gap in bipolar disorder'. J Affect Disord 67:61-78.
4. Brown ES, Carmody TJ, Schmitz JM, Caetano R, Adinoff B, Swann AC, John Rush A (2009) A randomized, double-blind, placebo-controlled pilot study of naltrexone in outpatients with bipolar disorder and alcohol dependence. Alcohol Clin Exp Res 33:1863-1869.
5. Brown ES, Garza M, Carmody TJ (2008) A randomized, double-blind, placebo-controlled add-on trial of quetiapine in outpatients with bipolar disorder and alcohol use disorders. J Clin Psychiatry 69:701-705.
6. Dalton EJ, Cate-Carter TD, Mundo E, Parikh SV, Kennedy JL (2003) Suicide risk in bipolar patients: the role of co-morbid substance use disorders. Bipolar Disord 5:58-61.
7. First MB, Spitzer RL, Gibbon M, William JBW (1995) Structured Clinical Interview for DSM-IV Axis I Disorders. Biometrics Research Department, New York State Psychiatric Institute, Department of Psychiatry, Columbia University, New York, NY.
8. Flannery BA, Volpicelli JR, Pettinati HM (1999) Psychometric properties of the Penn Alcohol Craving Scale. Alcohol Clin Exp Res 23:1289-1295.
9. Geddes JR, Calabrese JR, Goodwin GM (2009) Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials. Br J Psychiatry 194:4-9.
10. Geddes JR, Miklowitz DJ (2013) Treatment of bipolar disorder. Lancet 381:1672-1682.
11. Guardia J, Roncero C, Galan J, Gonzalvo B, Burguete T, Casas M (2011) A double-blind, placebo-controlled, randomized pilot study comparing quetiapine with placebo, associated to naltrexone, in the treatment of alcohol-dependent patients. Addict Behav 36:265-269.
12. Guy W (1976) ECDEU Assessment Manual for Psychopharmacology: Revised (DHEW publication number ADM 76-338), pp 534-537. US Department of Health, Education and Welfare, Public Health Service, Alcohol, Drug Abuse and Mental Health Administration, NIMH Psychopharmacology Research Branch, Division of Extramural Research Programs, Rockville, MD.
13. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-62.
14. Kampman KM, Pettinati HM, Lynch KG, Whittingham T, Macfadden W, Dackis C, Tirado C, Oslin DW, Sparkman T, O'Brien CP (2007) A double-blind, placebo-controlled pilot trial of quetiapine for the treatment of Type A and Type B alcoholism. J Clin Psychopharmacol 27:344-351.
15. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE (2005) Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62:593-602.
16. Lehman AF, Myers CP, Dixon LB, Johnson JL (1994) Defining subgroups of dual diagnosis patients for service planning. Hosp Community Psychiatry 45:556-561.
17. Litten RZ, Fertig JB, Falk DE, Ryan ML, Mattson ME, Collins JF, Murtaugh C, Ciraulo D, Green AI, Johnson B, Pettinati H, Swift R, Afshar M, Brunette MF, Tiouririne NA, Kampman K, Stout R; NCIG 001 Study Group (2012) A double-blind, placebo-controlled trial to assess the efficacy of quetiapine fumarate XR in very heavy-drinking alcohol-dependent patients. Alcohol Clin Exp Res 36:406-416.
18. McLellan AT, Luborsky L, Woody GE, O'Brien CP (1980) An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. J Nerv Ment Dis 168:26-33.
19. Nasrallah HA, Brecher M, Paulsson B (2006) Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania. Bipolar Disord 8(5 Pt 1): 467-474.
20. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, Goodwin FK (1990) Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 264:2511-2518.
21. Rush AJ, Gullion CM, Basco MR, Jarrett RB, Trivedi MH (1996) The Inventory of Depressive Symptomatology (IDS): psychometric properties. Psychol Med 26:477-486.
22. Salloum IM, Cornelius JR, Daley DC, Kirisci L, Himmelhoch JM, Thase ME (2005) Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study. Arch Gen Psychiatry 62:37-45.
23. Sanford M, Keating GM (2012) Quetiapine: a review of its use in the management of bipolar depression. CNS Drugs 26:435-460.
24. Schmitz JM, Averill P, Sayre S, McCleary P (2002) Cognitive-behavioral treatment of bipolar disorder and substance abuse: a preliminary randomized study. Addict Disord Their Treat 1:17-24.
25. Simpson GM, Angus JW (1970) A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl 212:11-19.
26. Singh J, Mattoo SK, Sharan P, Basu D (2005) Quality of life and its correlates in patients with dual diagnosis of bipolar affective disorder and substance dependence. Bipolar Disord 7:187-191.
27. Sobell L, Sobell M (1992) Timeline followback: a technique for assessing self-reported alcohol consumption, in Measuring Alcohol Consumption: Psychosocial and Biological Methods (Litten R, Allen J eds), pp 41-72. Humana Press, Totowa, NJ.
28. Sonne SC, Brady KT, Morton WA (1994) Substance abuse and bipolar affective disorder. J Nerv Ment Dis 182:349-352.
29. Spielmans GI, Berman MI, Linardatos E, Rosenlicht NZ, Perry A, Tsai AC (2013) Adjunctive atypical antipsychotic treatment for major depressive disorder: a meta-analysis of depression, quality of life, and safety outcomes. PLoS Med 10:e1001403.
30. Stedman M, Pettinati HM, Brown ES, Kotz M, Calabrese JR, Raines S (2010) A double-blind, placebo-controlled study with quetiapine as adjunct therapy with lithium or divalproex in bipolar I patients with coexisting alcohol dependence. Alcohol Clin Exp Res 34:1822-1831.
31. Sullivan JT, Sykora K, Schneiderman J, Naranjo CA, Sellers EM (1989) Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br J Addict 84:1353-1357.
32. Thase ME, Fava M, Halbreich U, Kocsis JH, Koran L, Davidson J, Rosenbaum J, Harrison W (1996) A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia. Arch Gen Psychiatry 53:777-784.
33. Young RC, Biggs JT, Ziegler VE, Meyer DA (1978) A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 133:429-435.